165 related articles for article (PubMed ID: 32983981)
1. Clinical Significance, Cellular Function, and Potential Molecular Pathways of CCT7 in Endometrial Cancer.
Wang L; Zhou W; Li H; Yang H; Shan N
Front Oncol; 2020; 10():1468. PubMed ID: 32983981
[No Abstract] [Full Text] [Related]
2. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of chaperonin containing TCP1 subunit 7 has diagnostic and prognostic value for hepatocellular carcinoma.
Huang X; Wang H; Xu F; Lv L; Wang R; Jiang B; Liu T; Hu H; Jiang Y
Aging (Albany NY); 2022 Jan; 14(2):747-769. PubMed ID: 35073517
[TBL] [Abstract][Full Text] [Related]
4. Effect of integrin α7 on cell proliferation, invasion, apoptosis and the PI3K/AKT pathway, and its association with clinicopathological features in endometrial cancer.
Liang M; Liu C; Lei T; Guo S; Min J
Oncol Lett; 2023 Jan; 25(1):26. PubMed ID: 36478908
[TBL] [Abstract][Full Text] [Related]
5. Silencing of UCA1, a poor prognostic factor, inhibited the migration of endometrial cancer cell.
Lu L; Shen Y; Tseng KF; Liu W; Duan H; Meng W
Cancer Biomark; 2016 Jun; 17(2):171-7. PubMed ID: 27540975
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
7. p53, Pirh2, and L1CAM as Promising Prognostic Biomarkers of Endometrial Carcinoma: An Immunohistochemical and Genetic Study.
Abdelrahman AE; Salem A; Al Attar AZ; Elsebai E; Samy W; Ibrahim MA; Ibrahim HM
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):713-725. PubMed ID: 36251972
[TBL] [Abstract][Full Text] [Related]
8. Tumor stiffness measured by 3D magnetic resonance elastography can help predict the aggressiveness of endometrial carcinoma: preliminary findings.
Zhang L; Long X; Nijiati M; Zhang T; Li M; Deng Y; Kuang S; Xiao Y; Zhu J; He B; Chen J; Rossman P; Glaser KJ; Venkatesh SK; Ehman RL; Wang J
Cancer Imaging; 2021 Aug; 21(1):50. PubMed ID: 34454623
[TBL] [Abstract][Full Text] [Related]
9. PCAT1 is a poor prognostic factor in endometrial carcinoma and associated with cancer cell proliferation, migration and invasion.
Zhao X; Fan Y; Lu C; Li H; Zhou N; Sun G; Fan H
Bosn J Basic Med Sci; 2019 Aug; 19(3):274-281. PubMed ID: 31136293
[TBL] [Abstract][Full Text] [Related]
10. NCAPH is upregulated in endometrial cancer and associated with poor clinicopathologic characteristics.
Qiu X; Gao Z; Shao J; Li H
Ann Hum Genet; 2020 Nov; 84(6):437-446. PubMed ID: 32628282
[TBL] [Abstract][Full Text] [Related]
11. FcRn Expression in Endometrial Cancer and Its Association with Clinicopathologic Features.
Song DH; Yang J; Kim CH; Kim MH; Jo JY; Baek JC
Diagnostics (Basel); 2023 Dec; 13(24):. PubMed ID: 38132243
[TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA-ATB Impairs the Function of Tumor Suppressor miR-126-Mediated Signals in Endometrial Cancer for Tumor Growth and Metastasis.
Zheng X; Liu M; Song Y; Feng C
Cancer Biother Radiopharm; 2019 Feb; 34(1):47-55. PubMed ID: 30601064
[TBL] [Abstract][Full Text] [Related]
13. BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma.
Li Y; Huo J; He J; Zhang Y; Ma X
Cancer Cell Int; 2020; 20():490. PubMed ID: 33041670
[TBL] [Abstract][Full Text] [Related]
14. [Expression and clinical significance of MIIP and PAK1 in endometrial carcinoma].
Jiang S; Tian WY; Yan Y; Teng F; Gao JP; Wang YM; Xue FX
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):359-364. PubMed ID: 29860763
[No Abstract] [Full Text] [Related]
15. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.
Nagase Y; Hiramatsu K; Funauchi M; Shiomi M; Masuda T; Kakuda M; Nakagawa S; Miyoshi A; Matsuzaki S; Kobayashi E; Kimura T; Serada S; Ueda Y; Naka T; Kimura T
BMC Cancer; 2022 Jun; 22(1):679. PubMed ID: 35729527
[TBL] [Abstract][Full Text] [Related]
16. Expression of Selected Epithelial-Mesenchymal Transition Transcription Factors in Endometrial Cancer.
Sadłecki P; Jóźwicki J; Antosik P; Walentowicz-Sadłecka M
Biomed Res Int; 2020; 2020():4584250. PubMed ID: 33457409
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA BANCR Promotes Endometrial Cancer Cell Proliferation and Invasion by Regulating MMP2 and MMP1 via ERK/MAPK Signaling Pathway.
Wang D; Wang D; Wang N; Long Z; Ren X
Cell Physiol Biochem; 2016; 40(3-4):644-656. PubMed ID: 27898420
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging.
Green RW; Epstein E
Ultrasound Obstet Gynecol; 2020 Jul; 56(1):96-105. PubMed ID: 31647145
[TBL] [Abstract][Full Text] [Related]
20. Histological Prognostic Factors of Endometrial Cancer in Patients with Adenomyosis: A Systematic Review and Meta-Analysis.
Raffone A; Travaglino A; Raimondo D; Maletta M; Salucci P; Santoro A; Zullo F; Zannoni GF; Casadio P; Seracchioli R; Mollo A
Pathobiology; 2022; 89(3):127-134. PubMed ID: 35051948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
